SOPHYSA

SOPHYSA is a French medical device manufacturer with 50 years of expertise in cerebrospinal fluid (CSF) management and neuromonitoring solutions. Headquartered in Orsay, France with manufacturing and R&D in Besançon, the company serves neurosurgery and neurocritical care specialties globally, including a US subsidiary in Crown Point, Indiana. SOPHYSA manufactures implantable and external drainage systems for hydrocephalus management, intracranial pressure (ICP) monitoring devices, and access ports for neurological applications. Core product lines include adjustable CSF shunting valves (Polaris®, Sophy® Mini SM8, Sophy® Mini SM1), anti-siphon devices (SiphonX®), external ventricular drainage systems and catheters, ICP/temperature monitoring catheters (Pressio® line), implantable access ports (Soph-A-Port®), and associated accessories and reservoirs. The Pressio® 2 system provides integrated intracranial pressure and temperature monitoring for critical care settings. All products are designed for MRI compatibility where applicable. The company serves hospitals, neurosurgical centers, and critical care facilities across multiple continents. Manufacturing capabilities include precision medical device fabrication with quality systems and regulatory compliance in multiple markets.